The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cho, H. J.
Right arrow Articles by Raz, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cho, H. J.
Right arrow Articles by Raz, E.
The Journal of Immunology, 2002, 168: 4907-4913.
Copyright © 2002 by The American Association of Immunologists

IFN-{alpha}{beta} Promote Priming of Antigen-Specific CD8+ and CD4+ T Lymphocytes by Immunostimulatory DNA-Based Vaccines1

Hearn Jay Cho2,*, Tomoko Hayashi{dagger}, Sandip K. Datta{dagger}, Kenji Takabayashi{dagger}, John Henry Van Uden{dagger}, Anthony Horner{dagger}, Maripat Corr{dagger} and Eyal Raz{dagger}

* Division of Hematology/Medical Oncology, Department of Medicine, New York Presbyterian Hospital and Cornell Medical Center, and Laboratory of Neuro-Oncology, Rockefeller University, New York, NY 10021; and {dagger} Department of Internal Medicine and The Sam and Rose Stein Institute for Research on Aging, University of California at San Diego, La Jolla, CA 92093

Immunostimulatory sequence (ISS) DNA containing unmethylated CpG dinucleotides stimulate NK and APC to secrete proinflammatory cytokines, including IFN-{alpha}{beta} and -{gamma}, TNF-{alpha}, and IL-6 and -12, and to express costimulatory surface molecules such as CD40, B7-1, and B7-2. Although ISS DNA has little direct effect on T cells by these criteria, immunization of wild-type mice with ISS DNA and OVA results in Ag-specific CTL and Th1-type T helper activity. This investigation examines the mechanisms by which ISS DNA primes CD8+ and CD4+ lymphocyte activities. In this report we demonstrate that ISS DNA regulates the expression of costimulatory molecules and TAP via a novel autocrine or paracrine IFN-{alpha}{beta} pathway. Coordinated regulation of B7 costimulation and TAP-dependent cross-presentation results in priming of Ag-specific CD8+ CTL, whereas CD40, B7, and IL-12 costimulation is required for priming of CD4+ Th cells by ISS-based vaccines.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
N. Zietara, M. Lyszkiewicz, N. Gekara, J. Puchalka, V. A. P. M. Dos Santos, C. R. Hunt, T. K. Pandita, S. Lienenklaus, and S. Weiss
Absence of IFN-{beta} Impairs Antigen Presentation Capacity of Splenic Dendritic Cells via Down-Regulation of Heat Shock Protein 70
J. Immunol., July 15, 2009; 183(2): 1099 - 1109.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. G. Sikora, N. Jaffarzad, Y. Hailemichael, A. Gelbard, S. W. Stonier, K. S. Schluns, L. Frasca, Y. Lou, C. Liu, H. A. Andersson, et al.
IFN-{alpha} Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor Activity
J. Immunol., June 15, 2009; 182(12): 7398 - 7407.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. D. Conrady, M. Thapa, T. Wuest, and D. J. J. Carr
Loss of Mandibular Lymph Node Integrity Is Associated with an Increase in Sensitivity to HSV-1 Infection in CD118-Deficient Mice
J. Immunol., March 15, 2009; 182(6): 3678 - 3687.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Q. Li, B. Xu, S. A. Michie, K. H. Rubins, R. D. Schreriber, and H. O. McDevitt
Interferon-{alpha} initiates type 1 diabetes in nonobese diabetic mice
PNAS, August 26, 2008; 105(34): 12439 - 12444.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Wang, L. Chen, E. Ahmed, L. Ma, D. Yin, P. Zhou, J. Shen, H. Xu, C.-R. Wang, M.-L. Alegre, et al.
Prevention of Allograft Tolerance by Bacterial Infection with Listeria monocytogenes
J. Immunol., May 1, 2008; 180(9): 5991 - 5999.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. Johansson, J. D. Wetzel, J. He, C. Mikacenic, T. S. Dermody, and B. L. Kelsall
Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus
J. Exp. Med., June 11, 2007; 204(6): 1349 - 1358.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
R. C. Gray, J. Kuchtey, and C. V. Harding
CpG-B ODNs potently induce low levels of IFN-{alpha}{beta} and induce IFN-{alpha}{beta}-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs
J. Leukoc. Biol., April 1, 2007; 81(4): 1075 - 1085.
[Abstract] [Full Text] [PDF]

Home page
 Plant Physiol.Home page
I.-P. Ahn, S. Kim, Y.-H. Lee, and S.-C. Suh
Vitamin B1-Induced Priming Is Dependent on Hydrogen Peroxide and the NPR1 Gene in Arabidopsis
Plant Physiology, February 1, 2007; 143(2): 838 - 848.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
R. S. Kornbluth and G. W. Stone
Immunostimulatory combinations: designing the next generation of vaccine adjuvants
J. Leukoc. Biol., November 1, 2006; 80(5): 1084 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Zaks, M. Jordan, A. Guth, K. Sellins, R. Kedl, A. Izzo, C. Bosio, and S. Dow
Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes.
J. Immunol., June 15, 2006; 176(12): 7335 - 7345.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Le Bon, C. Thompson, E. Kamphuis, V. Durand, C. Rossmann, U. Kalinke, and D. F. Tough
Cutting Edge: Enhancement of Antibody Responses Through Direct Stimulation of B and T Cells by Type I IFN
J. Immunol., February 15, 2006; 176(4): 2074 - 2078.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Wuthrich, T. Warner, and B. S. Klein
CD28 Is Required for Optimal Induction, but Not Maintenance, of Vaccine-Induced Immunity to Blastomyces dermatitidis
Infect. Immun., November 1, 2005; 73(11): 7436 - 7441.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. Sun, B. Tumurbaatar, J. Jia, H. Diao, F. Bodola, S. M. Lemon, W. Tang, D. G. Bowen, G. W. McCaughan, P. Bertolino, et al.
Parenchymal Expression of CD86/B7.2 Contributes to Hepatitis C Virus-Related Liver Injury
J. Virol., August 15, 2005; 79(16): 10730 - 10739.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Kuchtey, P. J. Chefalo, R. C. Gray, L. Ramachandra, and C. V. Harding
Enhancement of Dendritic Cell Antigen Cross-Presentation by CpG DNA Involves Type I IFN and Stabilization of Class I MHC mRNA
J. Immunol., August 15, 2005; 175(4): 2244 - 2251.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Kuwashima, F. Nishimura, J. Eguchi, H. Sato, M. Hatano, T. Tsugawa, T. Sakaida, J. E. Dusak, W. K. Fellows-Mayle, G. D. Papworth, et al.
Delivery of Dendritic Cells Engineered to Secrete IFN-{alpha} into Central Nervous System Tumors Enhances the Efficacy of Peripheral Tumor Cell Vaccines: Dependence on Apoptotic Pathways
J. Immunol., August 15, 2005; 175(4): 2730 - 2740.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
W. Jiang, M. M. Lederman, J. R. Salkowitz, B. Rodriguez, C. V. Harding, and S. F. Sieg
Impaired Monocyte Maturation in Response to CpG Oligodeoxynucleotide Is Related to Viral RNA Levels in Human Immunodeficiency Virus Disease and Is at Least Partially Mediated by Deficiencies in Alpha/Beta Interferon Responsiveness and Production
J. Virol., April 1, 2005; 79(7): 4109 - 4119.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Dikopoulos, A. Bertoletti, A. Kroger, H. Hauser, R. Schirmbeck, and J. Reimann
Type I IFN Negatively Regulates CD8+ T Cell Responses through IL-10-Producing CD4+ T Regulatory 1 Cells
J. Immunol., January 1, 2005; 174(1): 99 - 109.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Hiraoka, S. Yamamoto, S. Otsuru, S. Nakai, K. Tamai, R. Morishita, T. Ogihara, and Y. Kaneda
Enhanced Tumor-Specific Long-Term Immunity of Hemaggluttinating Virus of Japan-Mediated Dendritic Cell-Tumor Fused Cell Vaccination by Coadministration with CpG Oligodeoxynucleotides
J. Immunol., October 1, 2004; 173(7): 4297 - 4307.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Okada, T. Tsugawa, H. Sato, N. Kuwashima, A. Gambotto, K. Okada, J. E. Dusak, W. K. Fellows-Mayle, G. D. Papworth, S. C. Watkins, et al.
Delivery of Interferon-{alpha} Transfected Dendritic Cells into Central Nervous System Tumors Enhances the Antitumor Efficacy of Peripheral Peptide-Based Vaccines
Cancer Res., August 15, 2004; 64(16): 5830 - 5838.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Adams, G. T. Miller, M. I. Jesson, T. Watanabe, B. Jones, and B. P. Wallner
PT-100, a Small Molecule Dipeptidyl Peptidase Inhibitor, Has Potent Antitumor Effects and Augments Antibody-Mediated Cytotoxicity via a Novel Immune Mechanism
Cancer Res., August 1, 2004; 64(15): 5471 - 5480.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. B. Rosset, C. Ballerini, S. Gregoire, P. Metharom, C. Carnaud, and P. Aucouturier
Breaking Immune Tolerance to the Prion Protein Using Prion Protein Peptides Plus Oligodeoxynucleotide-CpG in Mice
J. Immunol., May 1, 2004; 172(9): 5168 - 5174.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. L. Ahonen, C. L. Doxsee, S. M. McGurran, T. R. Riter, W. F. Wade, R. J. Barth, J. P. Vasilakos, R. J. Noelle, and R. M. Kedl
Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN
J. Exp. Med., March 15, 2004; 199(6): 775 - 784.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Beloeil, M. Tomkowiak, G. Angelov, T. Walzer, P. Dubois, and J. Marvel
In Vivo Impact of CpG1826 Oligodeoxynucleotide on CD8 T Cell Primary Responses and Survival
J. Immunol., September 15, 2003; 171(6): 2995 - 3002.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Flynn and B. Stockinger
Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation
Blood, June 1, 2003; 101(11): 4472 - 4478.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
U. Kumaraguru, C. D. Pack, and B. T. Rouse
Toll-like receptor ligand links innate and adaptive immune responses by the production of heat-shock proteins
J. Leukoc. Biol., May 1, 2003; 73(5): 574 - 583.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. K. Datta, V. Redecke, K. R. Prilliman, K. Takabayashi, M. Corr, T. Tallant, J. DiDonato, R. Dziarski, S. Akira, S. P. Schoenberger, et al.
A Subset of Toll-Like Receptor Ligands Induces Cross-presentation by Bone Marrow-Derived Dendritic Cells
J. Immunol., April 15, 2003; 170(8): 4102 - 4110.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. Dalod, T. Hamilton, R. Salomon, T. P. Salazar-Mather, S. C. Henry, J. D. Hamilton, and C. A. Biron
Dendritic Cell Responses to Early Murine Cytomegalovirus Infection: Subset Functional Specialization and Differential Regulation by Interferon {alpha}/{beta}
J. Exp. Med., April 7, 2003; 197(7): 885 - 898.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.